BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7460038)

  • 1. [Immunological monitoring in patients with malignant melanoma (author's transl)].
    Uhrík J; Jurga L; Hejj F; Cichý A; Dubivská M; Gumanová Z
    Cesk Dermatol; 1980; 55(6):361-67. PubMed ID: 7460038
    [No Abstract]   [Full Text] [Related]  

  • 2. [Specific immune reactivity in patients with malignant melanoma (author's transl)].
    Poljak-Blazi M; Montani D; Ferle-Vidović A; Boranić M
    Lijec Vjesn; 1977 Dec; 99(12):735-8. PubMed ID: 607047
    [No Abstract]   [Full Text] [Related]  

  • 3. [Unspecific immunological investigations in patients with malignant melanoma (author's transl)].
    Knopf B; Wätzig V
    Dermatol Monatsschr; 1982 Jan; 168(1):24-33. PubMed ID: 7044849
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunoreactivity in patients with surgically removed melanoma in the course of BCG vaccination (author's transl)].
    Lochman I; Kyselá T; Machálek J; Lochmanová A; Beska F
    Cesk Dermatol; 1980; 55(6):372-7. PubMed ID: 7460040
    [No Abstract]   [Full Text] [Related]  

  • 5. [Some not tumorspecific immunological investigations in malignant neoplasms of skin (author's transl)].
    Salamon T; Stojaković M; Lazović-Tepavac O
    Dermatol Monatsschr; 1978 Oct; 164(10):720-6. PubMed ID: 738491
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-tumor immunoreactivity in patients with malignant melanoma.
    Nairn RC; Nind AP; Guli EP; Davies DJ; Little JH; Davis NC; Whitehead RH
    Med J Aust; 1972 Feb; 1(9):397-403. PubMed ID: 4554232
    [No Abstract]   [Full Text] [Related]  

  • 7. [Preliminary results of immuno-surgical treatment of primary melanoma (author's transl)].
    Vanwicjk R; Rustin P; Malek-Mansour S; Castermans-Elias S; Castermans A
    Acta Chir Belg; 1975 Jul; 74(4):430-40. PubMed ID: 1146463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative examinations of the effect of general and local anesthesia upon the T-lymphocytes in melanoma operations (author's transl)].
    Seebacher C; Bässler E
    Arch Geschwulstforsch; 1981; 51(2):179-86. PubMed ID: 6973960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Malignant melanoma in husband and wife (author's transl)].
    Schlaeger M; Tritsch H
    Dtsch Med Wochenschr; 1978 Jun; 103(23):968, 975-7. PubMed ID: 648396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunological conditions in patients with malignant melanoma of the skin].
    Kristensen E
    Ugeskr Laeger; 1976 Feb; 138(8):463-8. PubMed ID: 1258214
    [No Abstract]   [Full Text] [Related]  

  • 11. [A comparison of the morphofunctional characteristics of the peripheral blood lymphocytes and the immune status of patients with malignant melanoma of the skin].
    Naleskina LA; Ganina KP; Labunets IF; Grinevich IuA; Abramenko VA
    Tsitol Genet; 1996; 30(5):16-22. PubMed ID: 9026985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Deficiency of immunological systems as a cause of dermatophytic onychomycosis (author's transl)].
    Lestschenko WM; Fedotow WP
    Mykosen; 1982 May; 25(5):237-47. PubMed ID: 6212761
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experiments concerning the value of immunoglobulin-determinations (IgG, IgM, IgA) with respect to the immunological reactions of patients suffering from malignant tumors (author's transl)].
    Stiller D; Zucker G; Oehmer D; Hänsel H
    Allerg Immunol (Leipz); 1981; 27(1):14-21. PubMed ID: 6455051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in certain immunological parameters in patients with malignant skin melanoma].
    Lukács L; Bárdosi L; Somos Z; Kocsis B
    Orv Hetil; 1985 Apr; 126(14):819-26. PubMed ID: 3873050
    [No Abstract]   [Full Text] [Related]  

  • 15. [Delayed hypersensitivity reaction in malignant melanoma].
    Gorodilova VV; Saraeva ZM; Slesareva RI; Monzul' GD
    Vopr Onkol; 1973; 19(3):23-7. PubMed ID: 4762691
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hormonal function of the thymus in malignant melanoma of the skin; the interrelation with immune system disorders].
    Grinevich IuA; Labunets IF
    Vopr Onkol; 1987; 33(6):46-52. PubMed ID: 3617600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated immunity against malignant melanoma in monozygous twins.
    Nagel GA; St Arneault G; Holland JF; Kirkpatrick D; Kirkpatrick R
    Cancer Res; 1970 Jun; 30(6):1828-32. PubMed ID: 5466283
    [No Abstract]   [Full Text] [Related]  

  • 18. [Contribution to treatment of malignant melanoblastoma by the local application of DNCB (author's transl)].
    Duchková H; Richter J; Kubíková M
    Cesk Dermatol; 1978 Jun; 53(3):169-72. PubMed ID: 679282
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunological aspects of psoriasis (author's transl)].
    Vosmík F; Hausner P; Votava L; Fucíková T; Pekárek J
    Cesk Dermatol; 1979 Jun; 54(3):123-31. PubMed ID: 316365
    [No Abstract]   [Full Text] [Related]  

  • 20. [Autoantibodies in the serum of patients with malignant melanoma].
    Młodkowska A; Danowska A
    Pol Przegl Chir; 1978 Oct; 50(10):841-3. PubMed ID: 310545
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.